132 related articles for article (PubMed ID: 19921131)
1. The EGF 61A/G polymorphism - a predictive marker for recurrence of liver metastases from colorectal cancer.
Kovar FM; Thallinger C; Marsik CL; Perkmann T; Puhalla H; Haslacher H; Wrba F; Wagner OF; Gruenberger T; Endler G
Wien Klin Wochenschr; 2009; 121(19-20):638-43. PubMed ID: 19921131
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implication of EGF A61G Polymorphism in the Risk of Non Small Cell Lung Adenocarcinoma Patients: A Case Control Study.
Masroor M; Amit J; Javid J; Mir R; Prasant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
Asian Pac J Cancer Prev; 2015; 16(17):7529-34. PubMed ID: 26625757
[TBL] [Abstract][Full Text] [Related]
3. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
4. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
5. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study.
de Mello RA; Ferreira M; Costa S; Costa BM; Pires FS; Neves I; Almeida MI; Cunha J; Oliveira P; Hespanhol V; Reis RM
Tumour Biol; 2012 Oct; 33(5):1341-8. PubMed ID: 22457050
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
7. Association of Epidermal Growth Factor 61A>G, Survivin -31G>C, and EFNA1 -1732G>A Polymorphisms with Susceptibility to Colorectal Cancer.
Asadian F; Ghadyani M; Antikchi MH; Dastgheib SA; Neamatzadeh H; Sheikhpour E; Khajehnoori S; Tabei SS
J Gastrointest Cancer; 2022 Mar; 53(1):78-83. PubMed ID: 33180239
[TBL] [Abstract][Full Text] [Related]
8. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
Tanabe KK; Lemoine A; Finkelstein DM; Kawasaki H; Fujii T; Chung RT; Lauwers GY; Kulu Y; Muzikansky A; Kuruppu D; Lanuti M; Goodwin JM; Azoulay D; Fuchs BC
JAMA; 2008 Jan; 299(1):53-60. PubMed ID: 18167406
[TBL] [Abstract][Full Text] [Related]
10. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
11. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer.
Kang HG; Choi JE; Lee WK; Kam S; Cha SI; Kim CH; Jung TH; Park JY
Respirology; 2007 Nov; 12(6):902-5. PubMed ID: 17986122
[TBL] [Abstract][Full Text] [Related]
12. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
[TBL] [Abstract][Full Text] [Related]
13. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
14. EGF+61 A>G polymorphism does not predict response to first-generation EGFR tyrosine kinase inhibitors in lung cancer patients.
Leal LF; Laus AC; Cavagna R; de Paula FE; de Oliveira MA; Ribeiro DM; Hassan FM; Miziara JE; da Silva ECA; da Silva VD; De Marchi P; Reis RM
Thorac Cancer; 2020 Oct; 11(10):2987-2992. PubMed ID: 32881389
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
17. Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.
Casula M; Alaibac M; Pizzichetta MA; Bono R; Ascierto PA; Stanganelli I; Canzanella S; Palomba G; Zattra E; ; Palmieri G
BMC Dermatol; 2009 Jul; 9():7. PubMed ID: 19624835
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
[TBL] [Abstract][Full Text] [Related]
19. Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer.
Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
Oncol Res; 2008; 17(4):167-74. PubMed ID: 18773861
[TBL] [Abstract][Full Text] [Related]
20. Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer.
Crowe PJ; Yang JL; Berney CR; Erskine C; Ham JM; Fisher R; Russell PJ
World J Surg; 2001 Aug; 25(8):996-1001. PubMed ID: 11571982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]